黄芪保心汤联合西医治疗扩张型 心肌病并发慢性心力衰竭
CSTR:
作者:
作者单位:

(息县人民医院,河南 息县 464300)

作者简介:

孙志周,男,主治医师,主要研究方向是小儿内科学。

通讯作者:

中图分类号:

R 541

基金项目:


Effect of Huangqi Baoxin Decoction Combined with Western Medicine in the Treatment of Dilated Cardiomyopathy Complicated with Chronic Heart Failure
Author:
Affiliation:

(Xixian People's Hospital, Henan Xixian 464300)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕 目的:分析黄芪保心汤联合西医常规治疗对扩张型心肌病并发慢性心力衰竭患者心功能及再入院率的影 响。方法:选择 95 例扩张型心肌病并发慢性心力衰竭患者,从息县人民医院 2019 年 9 月至 2020 年 8 月期间选取, 根据治疗方案不同分成对照组 45 例,观察组 50 例。对照组患者给予西医常规治疗,观察组患者给予黄芪保心汤联合 西医常规治疗。比较两组患者的疗效、左心室射血分数(LVEF)、6 min 步行距离、中医证候积分、血清醛固酮(ALD)、 血管紧张素 Ⅱ(AngⅡ)、血浆肾素活性(PRA)和再入院率。结果:治疗总有效率方面观察组患者(94.00 %)高于 对照组(73.33 %),差异具有统计学意义(P < 0.05)。在心功能方面观察组患者治疗后 6 min 步行距离长于对照 组,LVEF 高于对照组,差异具有统计学意义(P < 0.05)。在中医证候积分方面观察组患者治疗后气促喘咳、心悸 胸闷、神疲乏力、青筋暴露、下肢浮肿评分均低于对照组,差异具有统计学意义(P < 0.05)。观察组患者治疗后血 清 AngⅡ、PRA、ALD 水平均低于对照组,差异具有统计学意义(P < 0.05)。观察组患者的再入院率〔2.00 %(1/50)〕 低于对照组〔15.56 %(7/45)〕,差异具有统计学意义(P < 0.05)。结论:黄芪保心汤联合西医常规治疗扩张型心 肌病并发慢性心力衰竭,其机制有可能和其抑制肾素 – 血管紧张素 – 醛固酮系统过度激活、保护内皮功能、抑制心室 重构相关,可显著改善患者心功能和肾素 – 血管紧张素 – 醛固酮系统,降低再入院率。

    Abstract:

    〔Abstract〕 Objective To analyze the effects of Huangqi Baoxin decoction combined with western medicine routine on cardiac function and readmission rate of patients with dilated cardiomyopathy complicated with chronic heart failure. Methods A total of 95 patients with dilated cardiomyopathy complicated with chronic heart failure in Xixian People's Hospital from September 2019 to August 2020 were selected and divided into a control group with 45 cases and an observation group with 50 cases according to difference treatment. The control group received conventional treatment of western medicine, and the observation group received Huangqi Baoxin decoction combined with conventional western medicine treatment. The efficacy, left ventricular ejection fraction (LVEF), 6 min walking distance, traditional Chinese medicine (TCM) syndrome score, serum aldosterone (ALD), angiotensin Ⅱ (AngⅡ), plasma renin activity (PRA) and readmission rate of the two groups were compared. Results The total effective rate in the observation group was 94.00%, higher than 73.33% in the control group, and the difference was statistically significant (P < 0.05). In terms of cardiac function, the walking distance 6 minutes after treatment in the observation group was longer than that in the control group, and the level of LVEF was higher than that in the control group, and the differences were statistically significant (P < 0.05). In terms of TCM syndrome score, the scores of shortness of breath, wheezing cough, palpitations, chest tightness, fatigue, exposure of green tendons and edema of lower limbs in the observation group were lower than those in the control group after treatment, with statistical significances (P < 0.05). After treatment, the levels of serum AngⅡ, PRA and ALD in the observation group were lower than those in the control group, the differences were statistically significant (P < 0.05). The readmission rate of the observation group [2.00 % (1/50)] was lower than that of the control group [15.56 % (7/45)], and the difference was statistically significant (P < 0.05). Conclusion Huangqi Baoxin decoction combined with conventional western medicine in the treatment of dilated cardiomyopathy complicated with chronic heart failure, the mechanism may be related to its inhibition of excessive activation of the renin angiotensin aldosterone system, protection of endothelial function, and inhibition of ventricular remodeling, which can significantly improve the patient's cardiac function and renin-angiotensin-aldosterone system, and reduce the readmission rate.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-02-21
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-11
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭